SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 48 filers reported holding SCPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,765 | -85.0% | 20,894 | -80.9% | 0.00% | – |
| Q1 2023 | $989,827 | +423.8% | 109,132 | +314.1% | 0.00% | – |
| Q4 2022 | $188,965 | -73.2% | 26,355 | -77.1% | 0.00% | – |
| Q2 2021 | $704,000 | -83.7% | 115,264 | -82.2% | 0.00% | -100.0% |
| Q1 2021 | $4,314,000 | +1954.3% | 648,770 | +1531.4% | 0.00% | – |
| Q4 2020 | $210,000 | -20.5% | 39,768 | +12.0% | 0.00% | – |
| Q3 2020 | $264,000 | +88.6% | 35,494 | +86.7% | 0.00% | – |
| Q2 2020 | $140,000 | +10.2% | 19,012 | +10.9% | 0.00% | – |
| Q1 2020 | $127,000 | +101.6% | 17,148 | +59.7% | 0.00% | – |
| Q3 2018 | $63,000 | -72.4% | 10,737 | -73.3% | 0.00% | – |
| Q2 2018 | $228,000 | -40.8% | 40,287 | +29.6% | 0.00% | – |
| Q1 2018 | $385,000 | -41.0% | 31,086 | -42.5% | 0.00% | – |
| Q4 2017 | $653,000 | – | 54,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,561,474 | $17,166,000 | 4.25% |
| AIGH Capital Management LLC | 1,346,724 | $6,491,000 | 1.71% |
| Worth Venture Partners, LLC | 335,985 | $1,784,000 | 1.05% |
| Ikarian Capital, LLC | 884,008 | $4,261,000 | 0.78% |
| Orbimed Advisors | 4,797,148 | $23,122,000 | 0.42% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $13,014,000 | 0.23% |
| Sandy Cove Advisors, LLC | 10,592 | $51,000 | 0.05% |
| Belvedere Trading LLC | 239,219 | $1,270,000 | 0.04% |
| IPG Investment Advisors LLC | 14,300 | $69,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $637,000 | 0.02% |